Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for Priority Review to be given. Explore more details here.

KDEV) today announces that its portfolio company Dilafor has successfully completed regulatory meetings with the U.S. Food and Drug Administration, FDA, and European Health Agencies, regarding the ...

The pair keeps the negative outlook below the 100-day EMA with the bearish RSI indicator. The first downside target emerges ...

The Pound Sterling exhibits a sharp volatility contraction around 1.2450 against the US Dollar on Thursday. The near-term ...

AstraZeneca PLC (LON:AZN), a leading global biopharmaceutical company with a market capitalization of $216.74 billion, has been making significant strides in the pharmaceutical industry, particularly ...

To report SUSPECTED ADVERSE REACTIONS, contact Zevra Therapeutics, Inc. at toll-free phone 1-844-600-2237 or FDA at 1‐800-FDA-1088 or .

During my daily analysis of European indices, the FTSE 100 has caught my attention as it looks like we are still stuck in a ...